Polydex Pharmaceuticals Ltd. | Cash Flow
Fiscal year is February-January. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
658.90
578.20
1,277.50
669.30
448.00
230.90
Depreciation, Depletion & Amortization
100.70
121.60
203.00
218.30
250.20
275.30
Other Funds
77.30
58.60
79.00
-
1.50
25.60
Funds from Operations
836.90
758.30
1,352.90
1,070.20
718.90
469.40
Changes in Working Capital
111.00
12.00
41.40
541.90
430.50
264.60
Net Operating Cash Flow
725.90
746.30
1,394.30
528.30
288.40
734
Capital Expenditures
294.40
367.70
200.00
295.40
374.60
Sale of Fixed Assets & Businesses
-
-
-
-
1.50
Purchase/Sale of Investments
0.80
46.20
-
540.00
16.90
Net Investing Cash Flow
295.20
413.90
200.00
835.40
390.00
Issuance/Reduction of Debt, Net
7.40
49.40
644.70
99.80
82.00
Net Financing Cash Flow
7.40
39.40
635.70
90.70
88.00
Net Change in Cash
355.40
131.50
451.40
289.30
20.70
Free Cash Flow
431.50
378.60
1,194.30
232.90
86.30
Deferred Taxes & Investment Tax Credit
-
-
206.60
182.70
22.20
62.50
Change in Capital Stock
-
10.00
9.00
9.20
6.00
Exchange Rate Effect
82.70
161.60
107.10
108.50
7.10
About Polydex Pharmaceuticals
View Profile
